Novo Nordisk A/S shares rose after Hims & Hers Health Inc. agreed to stop selling a copycat version of the new Wegovy weight-loss pill following US government threats to crack down on knockoffs. Bloomberg's Sam Fazeli reports. (Source: Bloomberg)

Novo’s shares plunged on Thursday after telehealth firm Hims & Hers Health Inc. launched a cheaper copycat version of its Wegovy pill that the Danish drugmaker says is illegal. Michael Shah of Bloomberg Intelligence has more. (Source: Bloomberg)